Machine translation;
H7N9 avian influenza pathogenesis and prevention measures
Post time :2013-04-05 12:23 Source: Health Editor: Yang Kun
......Human infection with the H7N9 avian flu prevention and control program
BEIJING, April 3 National Health and Family Planning Commission has announced on its official website of human infection with H7N9 avian flu.....according to the findings of the incubation period for influenza and the existing H7N9 avian influenza virus infection, the incubation period is generally within 7 days....
First, the etiology
The avian influenza virus, sticks to the case of the influenza A virus of the virus family. Avian influenza virus particles were pleomorphic, spherical diameter 80 to 120 nm, there is enveloped. The genome is a single strand segmented negative-strand RNA. Type based on its outer membrane hemagglutinin (H) and neuraminidase (N) protein antigens, can be divided into 16 H subtypes (H1 to H16) and 9 N subtypes (N1-N9). Avian influenza virus infected poultry, can also infect humans, pigs, horses, mink and marine mammals. Can be infected with the avian influenza virus subtype H5N1, H9N2, H7N7, H7N2, H7N3, the reports of human infection of H7N9 avian influenza virus. The virus is new reassortant virus, its internal genes from the H9N2 avian influenza virus.
....
(A) the general performance.
Patients generally present flu-like symptoms, such as fever, cough with little phlegm, may be associated with headache, muscle aches, and general malaise. Patients with severe progression of the disease, manifested as severe pneumonia, mostly sustained in body temperature above 39 ℃, difficulty in breathing, may be associated with hemoptysis sputum; rapidly progressive acute respiratory distress syndrome, mediastinal emphysema, sepsis, shock, awareness disorders and acute kidney injury.
(B) laboratory tests.
1 blood. The total number of white blood cells is generally not high or lower. Patients with severe multi leukocytes and lymphocytes decreased, and low platelet count.
2 blood biochemical examination. Multi-creatine kinase, lactate dehydrogenase, aspartate aminotransferase, alanine aminotransferase, elevated C-reactive protein, myoglobin can be increased.
3 pathogen detection.
(1) nucleic acid detection. Patients with respiratory specimens (eg nasopharyngeal secretions, mouth gargle, tracheal aspirate material or airway epithelial cells) using real time PCR (or RT-PCR) detected the H7N9 avian influenza virus nucleic acid.....
Page 2
(C) chest radiograph. The lungs of patients with pneumonia sheet image. Patients with severe disease progressed rapidly, showed multiple lung ground glass opacities and pulmonary consolidation images can be combined with a small amount of pleural effusion. ARDS occurs, the lesions are widely distributed.
(D) the prognosis. Human infection with the H7N9 avian influenza in patients with severe poor prognosis. Prognostic factors may include the patient's age, underlying diseases, complications.
Fourth, diagnosis and differential diagnosis
(A) diagnosis. Epidemiological contact history, clinical manifestations and laboratory test results, may make the diagnosis of human infection of H7N9 avian influenza. In the case of the epidemiological history is unknown, based on clinical manifestations, laboratory examinations and laboratory test results, especially from patients with respiratory secretion samples isolated H7N9 avian influenza virus, or H7N9 avian influenza virus nucleic acid testing positive, can be diagnosed.
.....
Diagnostic criteria.
(1) suspected cases: in line with the clinical symptoms and blood, biochemical and chest imaging characteristics of influenza A viruses the universal primers positive side-by-side in addition to seasonal flu can have epidemiological contact history.
(2) confirmed cases: in line with suspected cases of diagnostic criteria, and respiratory secretion samples isolated H7N9 avian influenza virus or the H7N9 avian influenza virus nucleic acid testing positive.
Severe cases: pneumonia with respiratory failure or other organ failure in severe cases.
(B) the differential diagnosis. Should be noted that the highly pathogenic H5N1 avian influenza, seasonal influenza (including influenza A H1N1 influenza), bacterial pneumonia, severe acute respiratory syndrome (SARS), a new coronavirus pneumonia, adenovirus pneumonia, chlamydia pneumonia, mycoplasma pneumonia and other diseases in the differential diagnosis. The differential diagnosis mainly rely on pathogenic examination.
V. Treatment
(A) clinical diagnosis and diagnosis of patients should be treated in isolation.
(B) symptomatic treatment. Available oxygen, the application of antipyretic drugs, cough expectorant drugs.
(C) antiviral therapy. Antiviral drugs for influenza should be applied as soon as possible.
1 neuraminidase inhibitors: the choice of oseltamivir Wei (Oseltamivir) or zanamivir (zanamivir), the clinical application showed that the avian influenza virus H5N1 and H1N1 infection, suggesting that people infected with the H7N9 avian influenza virus effective. Adult dose of oseltamivir 75mg twice daily, severe dose may be doubled, the course of 5-7 days. Zanamivir adult dose of 10 mg twice daily inhalation.
2. Ion channel M2 blockers: laboratory data suggest of Amantadine Amantadine and rimantadine (Rimantadine) resistance is not recommended to be used alone.
(4) Chinese medicine treatment.
1 pestilential Fanfei the lung failure declared down
Symptoms: fever, cough, scanty sputum, headache, muscle and joint pain.
Governing law: heat Xuanfei
Reference prescription:
The mulberry leaves Honeysuckle Forsythia fried almonds the gypsum Anemarrhena reed rhizome Artemisia annua skullcap raw licorice
Decoction, daily 1-2 agent orally once every 4-6 hours.
Modified: cough worse plus loquat, Fritillaria.
Medicine: optional Shufeng detoxification capsules, capsules Lianhuaqingwen, Qing Kai Ling Injection.
( health )
Source: http://translate.googleusercontent.c...sx3SdaezjjgAQA
H7N9 avian influenza pathogenesis and prevention measures
Post time :2013-04-05 12:23 Source: Health Editor: Yang Kun
......Human infection with the H7N9 avian flu prevention and control program
BEIJING, April 3 National Health and Family Planning Commission has announced on its official website of human infection with H7N9 avian flu.....according to the findings of the incubation period for influenza and the existing H7N9 avian influenza virus infection, the incubation period is generally within 7 days....
First, the etiology
The avian influenza virus, sticks to the case of the influenza A virus of the virus family. Avian influenza virus particles were pleomorphic, spherical diameter 80 to 120 nm, there is enveloped. The genome is a single strand segmented negative-strand RNA. Type based on its outer membrane hemagglutinin (H) and neuraminidase (N) protein antigens, can be divided into 16 H subtypes (H1 to H16) and 9 N subtypes (N1-N9). Avian influenza virus infected poultry, can also infect humans, pigs, horses, mink and marine mammals. Can be infected with the avian influenza virus subtype H5N1, H9N2, H7N7, H7N2, H7N3, the reports of human infection of H7N9 avian influenza virus. The virus is new reassortant virus, its internal genes from the H9N2 avian influenza virus.
....
(A) the general performance.
Patients generally present flu-like symptoms, such as fever, cough with little phlegm, may be associated with headache, muscle aches, and general malaise. Patients with severe progression of the disease, manifested as severe pneumonia, mostly sustained in body temperature above 39 ℃, difficulty in breathing, may be associated with hemoptysis sputum; rapidly progressive acute respiratory distress syndrome, mediastinal emphysema, sepsis, shock, awareness disorders and acute kidney injury.
(B) laboratory tests.
1 blood. The total number of white blood cells is generally not high or lower. Patients with severe multi leukocytes and lymphocytes decreased, and low platelet count.
2 blood biochemical examination. Multi-creatine kinase, lactate dehydrogenase, aspartate aminotransferase, alanine aminotransferase, elevated C-reactive protein, myoglobin can be increased.
3 pathogen detection.
(1) nucleic acid detection. Patients with respiratory specimens (eg nasopharyngeal secretions, mouth gargle, tracheal aspirate material or airway epithelial cells) using real time PCR (or RT-PCR) detected the H7N9 avian influenza virus nucleic acid.....
Page 2
(C) chest radiograph. The lungs of patients with pneumonia sheet image. Patients with severe disease progressed rapidly, showed multiple lung ground glass opacities and pulmonary consolidation images can be combined with a small amount of pleural effusion. ARDS occurs, the lesions are widely distributed.
(D) the prognosis. Human infection with the H7N9 avian influenza in patients with severe poor prognosis. Prognostic factors may include the patient's age, underlying diseases, complications.
Fourth, diagnosis and differential diagnosis
(A) diagnosis. Epidemiological contact history, clinical manifestations and laboratory test results, may make the diagnosis of human infection of H7N9 avian influenza. In the case of the epidemiological history is unknown, based on clinical manifestations, laboratory examinations and laboratory test results, especially from patients with respiratory secretion samples isolated H7N9 avian influenza virus, or H7N9 avian influenza virus nucleic acid testing positive, can be diagnosed.
.....
Diagnostic criteria.
(1) suspected cases: in line with the clinical symptoms and blood, biochemical and chest imaging characteristics of influenza A viruses the universal primers positive side-by-side in addition to seasonal flu can have epidemiological contact history.
(2) confirmed cases: in line with suspected cases of diagnostic criteria, and respiratory secretion samples isolated H7N9 avian influenza virus or the H7N9 avian influenza virus nucleic acid testing positive.
Severe cases: pneumonia with respiratory failure or other organ failure in severe cases.
(B) the differential diagnosis. Should be noted that the highly pathogenic H5N1 avian influenza, seasonal influenza (including influenza A H1N1 influenza), bacterial pneumonia, severe acute respiratory syndrome (SARS), a new coronavirus pneumonia, adenovirus pneumonia, chlamydia pneumonia, mycoplasma pneumonia and other diseases in the differential diagnosis. The differential diagnosis mainly rely on pathogenic examination.
V. Treatment
(A) clinical diagnosis and diagnosis of patients should be treated in isolation.
(B) symptomatic treatment. Available oxygen, the application of antipyretic drugs, cough expectorant drugs.
(C) antiviral therapy. Antiviral drugs for influenza should be applied as soon as possible.
1 neuraminidase inhibitors: the choice of oseltamivir Wei (Oseltamivir) or zanamivir (zanamivir), the clinical application showed that the avian influenza virus H5N1 and H1N1 infection, suggesting that people infected with the H7N9 avian influenza virus effective. Adult dose of oseltamivir 75mg twice daily, severe dose may be doubled, the course of 5-7 days. Zanamivir adult dose of 10 mg twice daily inhalation.
2. Ion channel M2 blockers: laboratory data suggest of Amantadine Amantadine and rimantadine (Rimantadine) resistance is not recommended to be used alone.
(4) Chinese medicine treatment.
1 pestilential Fanfei the lung failure declared down
Symptoms: fever, cough, scanty sputum, headache, muscle and joint pain.
Governing law: heat Xuanfei
Reference prescription:
The mulberry leaves Honeysuckle Forsythia fried almonds the gypsum Anemarrhena reed rhizome Artemisia annua skullcap raw licorice
Decoction, daily 1-2 agent orally once every 4-6 hours.
Modified: cough worse plus loquat, Fritillaria.
Medicine: optional Shufeng detoxification capsules, capsules Lianhuaqingwen, Qing Kai Ling Injection.
( health )
Source: http://translate.googleusercontent.c...sx3SdaezjjgAQA
Comment